CS
MLNT

Credit Suisse’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Credit Suisse’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-91,311
Closed -$607K – 3545
2019
Q2 		$607K Buy
+91,311
New +$607K ﹤0.01% 2672